The classification error rate for this analysis also followed a clear trend: it initially remained at 36.4% for the first two components, improved significantly to 18.2% with three components, and then increased to 22.7% and 31.8% with four and five components, respectively ( Supplementary Figure S2B ).
← all excerpts
Metabolomics insights into doxorubicin and 5-fluorouracil combination therapy in triple-negative breast cancer: a xenograft mouse model study.
1
—
—